- •Contents
- •Contributors
- •1 Introduction
- •2.1 Posterior Compartment
- •2.2 Anterior Compartment
- •2.3 Middle Compartment
- •2.4 Perineal Body
- •3 Compartments
- •3.1 Posterior Compartment
- •3.1.1 Connective Tissue Structures
- •3.1.2 Muscles
- •3.1.3 Reinterpreted Anatomy and Clinical Relevance
- •3.2 Anterior Compartment
- •3.2.1 Connective Tissue Structures
- •3.2.2 Muscles
- •3.2.3 Reinterpreted Anatomy and Clinical Relevance
- •3.2.4 Important Vessels, Nerves, and Lymphatics of the Anterior Compartment
- •3.3 Middle Compartment
- •3.3.1 Connective Tissue Structures
- •3.3.2 Muscles
- •3.3.3 Reinterpreted Anatomy and Clinical Relevance
- •3.3.4 Important Vessels, Nerves, and Lymphatics of the Middle Compartment
- •4 Perineal Body
- •References
- •MR and CT Techniques
- •1 Introduction
- •2.1 Introduction
- •2.2.1 Spasmolytic Medication
- •2.3.2 Diffusion-Weighted Imaging
- •2.3.3 Dynamic Contrast Enhancement
- •3 CT Technique
- •3.1 Introduction
- •3.2 Technical Disadvantages
- •3.4 Oral and Rectal Contrast
- •References
- •Uterus: Normal Findings
- •1 Introduction
- •References
- •1 Clinical Background
- •1.1 Epidemiology
- •1.2 Clinical Presentation
- •1.3 Embryology
- •1.4 Pathology
- •2 Imaging
- •2.1 Technique
- •2.2.1 Class I Anomalies: Dysgenesis
- •2.2.2 Class II Anomalies: Unicornuate Uterus
- •2.2.3 Class III Anomalies: Uterus Didelphys
- •2.2.4 Class IV Anomalies: Bicornuate Uterus
- •2.2.5 Class V Anomalies: Septate Uterus
- •2.2.6 Class VI Anomalies: Arcuate Uterus
- •2.2.7 Class VII Anomalies
- •References
- •Benign Uterine Lesions
- •1 Background
- •1.1 Uterine Leiomyomas
- •1.1.1 Epidemiology
- •1.1.2 Pathogenesis
- •1.1.3 Histopathology
- •1.1.4 Clinical Presentation
- •1.1.5 Therapy
- •1.1.5.1 Indications
- •1.1.5.2 Medical Therapy and Ablation
- •1.1.5.3 Surgical Therapy
- •1.1.5.4 Uterine Artery Embolization (UAE)
- •1.1.5.5 Magnetic Resonance-Guided Focused Ultrasound
- •2 Adenomyosis of the Uterus
- •2.1 Epidemiology
- •2.2 Pathogenesis
- •2.3 Histopathology
- •2.4 Clinical Presentation
- •2.5 Therapy
- •3 Imaging
- •3.2 Magnetic Resonance Imaging
- •3.2.1 Magnetic Resonance Imaging: Technique
- •3.2.2 MR Appearance of Uterine Leiomyomas
- •3.2.3 Locations, Growth Patterns, and Imaging Characteristics
- •3.2.4 Histologic Subtypes and Forms of Degeneration
- •3.2.5 Differential Diagnosis
- •3.2.6 MR Appearance of Uterine Adenomyosis
- •3.2.7 Locations, Growth Patterns, and Imaging Characteristics
- •3.2.8 Differential Diagnosis
- •3.3 Computed Tomography
- •3.3.1 CT Technique
- •3.3.2 CT Appearance of Uterine Leiomyoma and Adenomyosis
- •3.3.3 Atypical Appearances on CT and Differential Diagnosis
- •4.1 Indications
- •4.2 Technique
- •Bibliography
- •Cervical Cancer
- •1 Background
- •1.1 Epidemiology
- •1.2 Pathogenesis
- •1.3 Screening
- •1.4 HPV Vaccination
- •1.5 Clinical Presentation
- •1.6 Histopathology
- •1.7 Staging
- •1.8 Growth Patterns
- •1.9 Treatment
- •1.9.1 Treatment of Microinvasive Cervical Cancer
- •1.9.2 Treatment of Grossly Invasive Cervical Carcinoma (FIGO IB-IVA)
- •1.9.3 Treatment of Recurrent Disease
- •1.9.4 Treatment of Cervical Cancer During Pregnancy
- •1.10 Prognosis
- •2 Imaging
- •2.1 Indications
- •2.1.1 Role of CT and MRI
- •2.2 Imaging Technique
- •2.2.2 Dynamic MRI
- •2.2.3 Coil Technique
- •2.2.4 Vaginal Opacification
- •2.3 Staging
- •2.3.1 General MR Appearance
- •2.3.2 Rare Histologic Types
- •2.3.3 Tumor Size
- •2.3.4 Local Staging
- •2.3.4.1 Stage IA
- •2.3.4.2 Stage IB
- •2.3.4.3 Stage IIA
- •2.3.4.4 Stage IIB
- •2.3.4.5 Stage IIIA
- •2.3.4.6 Stage IIIB
- •2.3.4.7 Stage IVA
- •2.3.4.8 Stage IVB
- •2.3.5 Lymph Node Staging
- •2.3.6 Distant Metastases
- •2.4 Specific Diagnostic Queries
- •2.4.1 Preoperative Imaging
- •2.4.2 Imaging Before Radiotherapy
- •2.5 Follow-Up
- •2.5.1 Findings After Surgery
- •2.5.2 Findings After Chemotherapy
- •2.5.3 Findings After Radiotherapy
- •2.5.4 Recurrent Cervical Cancer
- •2.6.1 Ultrasound
- •2.7.1 Metastasis
- •2.7.2 Malignant Melanoma
- •2.7.3 Lymphoma
- •2.8 Benign Lesions of the Cervix
- •2.8.1 Nabothian Cyst
- •2.8.2 Leiomyoma
- •2.8.3 Polyps
- •2.8.4 Rare Benign Tumors
- •2.8.5 Cervicitis
- •2.8.6 Endometriosis
- •2.8.7 Ectopic Cervical Pregnancy
- •References
- •Endometrial Cancer
- •1.1 Epidemiology
- •1.2 Pathology and Risk Factors
- •1.3 Symptoms and Diagnosis
- •2 Endometrial Cancer Staging
- •2.1 MR Protocol for Staging Endometrial Carcinoma
- •2.2.1 Stage I Disease
- •2.2.2 Stage II Disease
- •2.2.3 Stage III Disease
- •2.2.4 Stage IV Disease
- •4 Therapeutic Approaches
- •4.1 Surgery
- •4.2 Adjuvant Treatment
- •4.3 Fertility-Sparing Treatment
- •5.1 Treatment of Recurrence
- •6 Prognosis
- •References
- •Uterine Sarcomas
- •1 Epidemiology
- •2 Pathology
- •2.1 Smooth Muscle Tumours
- •2.2 Endometrial Stromal Tumours
- •3 Clinical Background
- •4 Staging
- •5 Imaging
- •5.1 Leiomyosarcoma
- •5.2.3 Undifferentiated Uterine Sarcoma
- •5.3 Adenosarcoma
- •6 Prognosis and Treatment
- •References
- •1.1 Anatomical Relationships
- •1.4 Pelvic Fluid
- •2 Developmental Anomalies
- •2.1 Congenital Abnormalities
- •2.2 Ovarian Maldescent
- •3 Ovarian Transposition
- •References
- •1 Introduction
- •4 Benign Adnexal Lesions
- •4.1.1 Physiological Ovarian Cysts: Follicular and Corpus Luteum Cysts
- •4.1.1.1 Imaging Findings in Physiological Ovarian Cysts
- •4.1.1.2 Differential Diagnosis
- •4.1.2 Paraovarian Cysts
- •4.1.2.1 Imaging Findings
- •4.1.2.2 Differential Diagnosis
- •4.1.3 Peritoneal Inclusion Cysts
- •4.1.3.1 Imaging Findings
- •4.1.3.2 Differential Diagnosis
- •4.1.4 Theca Lutein Cysts
- •4.1.4.1 Imaging Findings
- •4.1.4.2 Differential Diagnosis
- •4.1.5 Polycystic Ovary Syndrome
- •4.1.5.1 Imaging Findings
- •4.1.5.2 Differential Diagnosis
- •4.2.1 Cystadenoma
- •4.2.1.1 Imaging Findings
- •4.2.1.2 Differential Diagnosis
- •4.2.2 Cystadenofibroma
- •4.2.2.1 Imaging Features
- •4.2.3 Mature Teratoma
- •4.2.3.1 Mature Cystic Teratoma
- •Imaging Findings
- •Differential Diagnosis
- •4.2.3.2 Monodermal Teratoma
- •Imaging Findings
- •4.2.4 Benign Sex Cord-Stromal Tumors
- •4.2.4.1 Fibroma and Thecoma
- •Imaging Findings
- •4.2.4.2 Sclerosing Stromal Tumor
- •Imaging Findings
- •4.2.5 Brenner Tumors
- •4.2.5.1 Imaging Findings
- •4.2.5.2 Differential Diagnosis
- •5 Functioning Ovarian Tumors
- •References
- •1 Introduction
- •2.1 Context
- •2.2.2 Indications According to Simple Rules
- •References
- •CT and MRI in Ovarian Carcinoma
- •1 Introduction
- •2.1 Familial or Hereditary Ovarian Cancers
- •3 Screening for Ovarian Cancer
- •5 Tumor Markers
- •6 Clinical Presentation
- •7 Imaging of Ovarian Cancer
- •7.1.2 Peritoneal Carcinomatosis
- •7.1.3 Ascites
- •7.3 Staging of Ovarian Cancer
- •7.3.1 Staging by CT and MRI
- •Imaging Findings According to Tumor Stages
- •Value of Imaging
- •7.3.2 Prediction of Resectability
- •7.4 Tumor Types
- •7.4.1 Epithelial Ovarian Cancer
- •High-Grade Serous Ovarian Cancer
- •Low-Grade Serous Ovarian Cancer
- •Mucinous Epithelial Ovarian Cancer
- •Endometrioid Ovarian Carcinomas
- •Clear Cell Carcinomas
- •Imaging Findings of Epithelial Ovarian Cancers
- •Differential Diagnosis
- •Borderline Tumors
- •Imaging Findings
- •Differential Diagnosis
- •Recurrent Ovarian Cancer
- •Imaging Findings
- •Differential Diagnosis
- •Value of Imaging
- •Malignant Germ Cell Tumors
- •Dysgerminomas
- •Imaging Findings
- •Differential Diagnosis
- •Immature Teratomas
- •Imaging Findings
- •Malignant Transformation in Benign Teratoma
- •Imaging Findings
- •Differential Diagnosis
- •Sex-Cord Stromal Tumors
- •Granulosa Cell Tumors
- •Imaging Findings
- •Sertoli-Leydig Cell Tumor
- •Imaging Findings
- •Ovarian Lymphoma
- •Imaging Findings
- •Differential Diagnosis
- •7.4.3 Ovarian Metastases
- •Imaging Findings
- •Differential Diagnosis
- •7.5 Fallopian Tube Cancer
- •7.5.1 Imaging Findings
- •Differential Diagnosis
- •References
- •Endometriosis
- •1 Introduction
- •2.1 Sonography
- •3 MR Imaging Findings
- •References
- •Vagina and Vulva
- •1 Introduction
- •3.1 CT Appearance
- •3.2 MRI Protocol
- •3.3 MRI Appearance
- •4.1 Imperforate Hymen
- •4.2 Congenital Vaginal Septa
- •4.3 Vaginal Agenesis
- •5.1 Vaginal Cysts
- •5.1.1 Gardner Duct Cyst (Mesonephric Cyst)
- •5.1.2 Bartholin Gland Cyst
- •5.2.1 Vaginal Infections
- •5.2.1.1 Vulvar Infections
- •5.2.1.2 Vulvar Thrombophlebitis
- •5.3 Vulvar Trauma
- •5.4 Vaginal Fistula
- •5.5 Post-Radiation Changes
- •5.6 Benign Tumors
- •6.1 Vaginal Malignancies
- •6.1.1 Primary Vaginal Carcinoma
- •6.1.1.1 MRI Findings
- •6.1.1.2 Lymph Node Drainage
- •6.1.1.3 Recurrence and Complications
- •6.1.2 Non-squamous Cell Carcinomas of the Vagina
- •6.1.2.1 Adenocarcinoma
- •6.1.2.2 Melanoma
- •6.1.2.3 Sarcomas
- •6.1.2.4 Lymphoma
- •6.2 Vulvar Malignancies
- •6.2.1 Vulvar Carcinoma
- •6.2.2 Melanoma
- •6.2.3 Lymphoma
- •6.2.4 Aggressive Angiomyxoma of the Vulva
- •7 Vaginal Cuff Disease
- •7.1 MRI Findings
- •8 Foreign Bodies
- •References
- •Imaging of Lymph Nodes
- •1 Background
- •3 Technique
- •3.1.1 Intravenous Unspecific Contrast Agents
- •3.1.2 Intravenous Tissue-Specific Contrast Agents
- •References
- •1 Introduction
- •2.1.1 Imaging Findings
- •2.1.2 Differential Diagnosis
- •2.1.3 Value of Imaging
- •2.2 Pelvic Inflammatory
- •2.2.1 Imaging Findings
- •2.3 Hydropyosalpinx
- •2.3.1 Imaging Findings
- •2.3.2 Differential Diagnosis
- •2.4 Tubo-ovarian Abscess
- •2.4.1 Imaging Findings
- •2.4.2 Differential Diagnosis
- •2.4.3 Value of Imaging
- •2.5 Ovarian Torsion
- •2.5.1 Imaging Findings
- •2.5.2 Differential Diagnosis
- •2.5.3 Diagnostic Value
- •2.6 Ectopic Pregnancy
- •2.6.1 Imaging Findings
- •2.6.2 Differential Diagnosis
- •2.6.3 Value of Imaging
- •3.1 Pelvic Congestion Syndrome
- •3.1.1 Imaging Findings
- •3.1.2 Differential Diagnosis
- •3.1.3 Value of Imaging
- •3.2 Ovarian Vein Thrombosis
- •3.2.1 Imaging Findings
- •3.2.2 Differential Diagnosis
- •3.2.3 Value of Imaging
- •3.3 Appendicitis
- •3.3.1 Imaging Findings
- •3.3.2 Value of Imaging
- •3.4 Diverticulitis
- •3.4.1 Imaging Findings
- •3.4.2 Differential Diagnosis
- •3.4.3 Value of Imaging
- •3.5 Epiploic Appendagitis
- •3.5.1 Imaging Findings
- •3.5.2 Differential Diagnosis
- •3.5.3 Value of Imaging
- •3.6 Crohn’s Disease
- •3.6.1 Imaging Findings
- •3.6.2 Differential Diagnosis
- •3.6.3 Value of Imaging
- •3.7 Rectus Sheath Hematoma
- •3.7.1 Imaging Findings
- •3.7.2 Differential Diagnosis
- •3.7.3 Value of Imaging
- •References
- •MRI of the Pelvic Floor
- •1 Introduction
- •2 Imaging Techniques
- •3.1 Indications
- •3.2 Patient Preparation
- •3.3 Patient Instruction
- •3.4 Patient Positioning
- •3.5 Organ Opacification
- •3.6 Sequence Protocols
- •4 MR Image Analysis
- •4.1 Bony Pelvis
- •5 Typical Findings
- •5.1 Anterior Compartment
- •5.2 Middle Compartment
- •5.3 Posterior Compartment
- •5.4 Levator Ani Muscle
- •References
- •Evaluation of Infertility
- •1 Introduction
- •2 Imaging Techniques
- •2.1 Hysterosalpingography
- •2.1.1 Cycle Considerations
- •2.1.2 Technical Considerations
- •2.1.3 Side Effects and Complications
- •2.1.5 Pathological Findings
- •2.1.6 Limitations of HSG
- •2.2.1 Cycle Considerations
- •2.2.2 Technical Considerations
- •2.2.2.1 Normal and Abnormal Anatomy
- •2.2.3 Accuracy
- •2.2.4 Side Effects and Complications
- •2.2.5 Limitations of Sono-HSG
- •2.3 Magnetic Resonance Imaging
- •2.3.1 Indications
- •2.3.2 Technical Considerations
- •2.3.3 Limitations
- •3 Ovulatory Dysfunction
- •4 Pituitary Adenoma
- •5 Polycystic Ovarian Syndrome
- •7 Uterine Disorders
- •7.1 Müllerian Duct Anomalies
- •7.1.1 Class I: Hypoplasia or Agenesis
- •7.1.2 Class II: Unicornuate
- •7.1.3 Class III: Didelphys
- •7.1.4 Class IV: Bicornuate
- •7.1.5 Class V: Septate
- •7.1.6 Class VI: Arcuate
- •7.1.7 Class VII: Diethylstilbestrol Related
- •7.2 Adenomyosis
- •7.3 Leiomyoma
- •7.4 Endometriosis
- •References
- •MR Pelvimetry
- •1 Clinical Background
- •1.3.1 Diagnosis
- •1.3.2.1 Cephalopelvic Disproportion
- •1.3.4 Inadequate Progression of Labor due to Inefficient Contraction (“the Powers”)
- •2.2 Palpation of the Pelvis
- •3 MR Pelvimetry
- •3.2 MR Imaging Protocol
- •3.3 Image Analysis
- •3.4 Reference Values for MR Pelvimetry
- •5 Indications for Pelvimetry
- •References
- •MR Imaging of the Placenta
- •2 Imaging of the Placenta
- •3 MRI Protocol
- •4 Normal Appearance
- •4.1 Placenta Variants
- •5 Placenta Adhesive Disorders
- •6 Placenta Abruption
- •7 Solid Placental Masses
- •9 Future Directions
- •References
- •Erratum to: Endometrial Cancer
294 |
R. Forstner |
|
|
in benign teratomas may occur at any age group. Currently, there is no evidence of an advantage of PET/CT over MRI for characterization of complex adnexal masses (Lee and Catalano 2015; Iver and Lee 2010).
7.1.2\ Peritoneal Carcinomatosis
Peritoneal carcinomatosis is the typical pathway of tumor dissemination in advanced ovarian cancer (Fig. 5). It is determined by the complex anatomy of the peritoneal cavity and follows the clockwise pattern of the peritoneal fluid circulation along the paracolic gutters toward the diaphragm and downward (Lengyel 2010; Patel et al. 2011). Although all peritoneal parietal and visceral surfaces may be involved, common sites of peritoneal implants in ovarian cancer include greater omentum, paracolic gutters, the pouch of
a
Douglas, surfaces of the liver and diaphragm, and bowel surface. Less frequent sites of dissemination are the mesentery, splenic surface, along the porta hepatis, lesser sac, and the gastrosplenic ligament (Forstner et al. 2010; Nougaret et al. 2012). Peritoneal metastases are characterized by a broad spectrum of imaging findings. They may display as nodular soft tissue lesions or as more subtle findings including linear or plaquelike thickening of the parietal or visceral peritoneum (Fig. 6). Implants from serous tumors may display tiny calcifications only. Besides nodular lesions, thickening of the root of the mesentery with a stellate radiating pattern or ill-defined nodular lesions have been described in metastases of the mesentery (Fig. 7) (Nougaret et al. 2012). The majority of peritoneal lesions show moderate enhancement after IV contrast medium.
b
Fig. 5 Peritoneal implants. Findings in FIGO stage IIIC ovarian cancer are shown in an anterior (a) and posterior (b) coronal CT plane. Ascites, mild peritoneal thickening, and multiple solid peritoneal implants along the anterior abdominal wall and in the transverse
mesocolon (arrow) are demonstrated in (a). A large implant in the right paracolic gutter (arrow) resembles the morphology of the thick-walled cystic and solid adnexal tumors, which present bilateral ovarian cancer (b). U uterus
CT and MRI in Ovarian Carcinoma |
295 |
|
|
a |
b |
Fig. 6 Peritoneal implants. Coronal (a) and transaxial CT of the upper abdomen (b). Linear thickening of the parietal peritoneum is seen throughout the abdomen and pelvis in a patient with large amounts of ascites (a). The diffuse linear
thickening of the diaphragm is better appreciated on the transaxial plane (b). Other findings include bilateral focal diaphragmatic implants and broad band-like tumors (arrows) adjacent to the transverse colon presenting omental cake
Fig. 7 Diffuse mesenterial involvement in high-grade serous cancer. Ill-defined mesenterial linear and nodular lesions (arrow) are seen in the root of the mesentery
Rarely, mixed solid and cystic or purely cystic lesions are found. The latter may mimic loculated ascites; however linear enhancement or tiny mural nodules may indicate the tumorous deposits. In MRI delayed enhancement at 3–10 min after gadolinium has been described to improve the detection of peritoneal metastases (Low et al. 2005). The omentum accounts for the most common site of peritoneal metastases, with the inframesocolic
omentum more often involved than the supramesocolic omentum (Fig. 8). They are typically located between the abdominal wall and bowel loops. If they coalesce they are termed omental cake. Netlike omental involvement is more difficult to evaluate. In liver surface implants, peritoneal deposits of the liver capsule should be differentiated from invasive implants, as the latter usually are not resectable (Akin et al. 2008). Bowel surface or mesenterial implants can cause tethering of bowel loops and may lead to obstruction. However, this is more likely to occur in recurrent ovarian cancer (Low et al. 2003). Depiction of peritoneal implants depends on their size and on the presence of ascites. In CT the problem of diagnosing small peritoneal implants is expressed by the sensitivity of only 25–50% for lesion size of less than 1 cm in size (Coakley et al. 2002). The performance of CT, however, improved to a sensitivity of 85–93% and a specificity of 91–96% for peritoneal disease larger than 1 cm in size (Coakley et al. 2002). Although CT has been established as primary imaging modality to assess peritoneal malignant disease, MRI has the potential to become the new standard of the reference (Rockall 2014). It seems superior to CT
296 |
R. Forstner |
|
|
a |
b |
c |
d |
Fig. 8 Omental implants. Transaxial CT (a–c) and transaxial fat-saturated T1-weighted image (d) in four different patients. Omental implants (arrows) may display a broad
spectrum of findings ranging from a netlike pattern (a) to cotton-like (b) and nodular lesions (d)
a |
b |
c |
Fig. 9 Superiority of MRI (a, b) over CT (c) in visualization of small liver surface and diaphragmatic implants (arrows). The small deposits are best depicted on DWI (b = 800 mm2) (a)
CT and MRI in Ovarian Carcinoma |
297 |
|
|
in detecting peritoneal implants (Fig. 9), particularly in the absence of ascites (Low et al. 1999, 2015). Diffusion-weighted MR imaging enables direct visualization of implants at sites that are otherwise difficult to assess throughout the peritoneal cavity and is superior in pelvic imaging to CT (Rockall 2014). In a prospective comparative study with surgery as standard of reference, whole-body MRI using DWI was superior to CT and to PET/CT in assessing bowel serosal and mesenteric disease (Michielsen et al. 2014). Another comparative study found no significant differences between CT, MRI, and PET/CT in assessing ovarian cancer. In this study PET/CT was best for assessment of supradiaphragmatic metastases (Schmidt et al. 2015). It seems that currently the role of PET/CT for staging primary ovarian cancer staging is limited (Rockall 2014). Most studies report slightly improved lesion conspicuity of PET/CT (sens. of 77–100%) over CT alone (sens. of 60–97%) (Pfanneberg et al. 2013). In one study combined PET/CT achieved a sensitivity of 88% compared to 84% for CT and 63% for PET alone in patients undergoing hyperthermic intraperitoneal chemotherapy (Pfanneberg et al. 2013). In PET/CT false negatives may occur due to small tumor size (5–10 mm) and FDGnegative tumors (Patel et al. 2011). False positives may occur in nonmalignant and inflammatory peritoneal diseases (Michielsen et al. 2014; Pfanneberg et al. 2013).
7.1.3\ Ascites
Small amounts of pelvic fluid in the cul-de-sac present a physiological finding and may be found throughout the cycle in the reproductive age. Ascites is defined as fluid outside the pouch of Douglas according to the International Ovarian Tumor Analysis (IOTA) group (Timmerman et al. 2000). In ovarian cancer, pelvic ascites may be a finding of stage I disease. Large amounts of ascites in a patient with ovarian cancer usually indicate stage III disease. In ovarian cancer the presence of ascites alone had a PPV of 72–80% for peritoneal metastases (Coakley et al. 2002).
The absence of ascites may not exclude a malignant disease, as 50% of borderline tumors and 83% of early-stage ovarian cancers are not
associated with ascites (Ozols et al. 2001). Peritoneal carcinomatosis is characterized by various amounts of ascites and diffuse or focal peritoneal thickening. Benign forms of ascites displaying the same pattern, such as postoperative inflammatory changes, bacterial peritonitis including tuberculosis, or chronic hemodialysis, often cannot be differentiated from peritoneal carcinomatosis (Diop et al. 2014; Levy et al. 2009).
7.2\ Pathways of Spread
in Ovarian Cancer
Knowledge of the pathways of tumor spread is pivotal for the interpretations of findings in CT and MRI, and they are the basis for staging of ovarian cancer. Ovarian cancer spreads primarily by direct extension to neighboring organs, by exfoliating cells into the peritoneal cavity that can implant on parietal and visceral peritoneum throughout the peritoneal cavity. It also disseminates by lymphatic pathways and less commonly metastasizes hematogenously. Locoregional spread of ovarian cancer occurs by continuous growth along the surfaces of the pelvic organs and pelvic sidewalls. Peritoneal spread and implantation outside the pelvis is caused by tumor cells that are able to slough off the ovary and enter the peritoneal circulation. Peritoneal implants are also disseminated throughout the lymphatic vessels of the peritoneum.
Tumor spread along the lymphatic pathways is found along three routes. The main pathway of lymphatic spread is along the broad ligament and parametria to the pelvic sidewall lymph nodes (external iliac and obturator chains) and along the ovarian vessels to the upper common iliac and para-aortic lymph nodes between the renal hilum and aortic bifurcation. Drainage to external and inguinal nodes via the round ligaments accounts for the rarest route of lymphatic tumor spread. In advanced ovarian cancer, the presence of nodal spread is reported in 40–60% (Ozols et al. 2001; Bachmann et al. 2016). In a series of 130 patients mostly with serous ovarian cancer, the rate of nodal metastases was 75%. In almost half of the cases, both metastases